Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + amodiaquine and artemether + lumefantrine for uncomplicated falciparum malaria in children in Pointe-Noire
ACTRN12615001110572Phase 4Completed
- Sponsor
- Ministry of Health and Population
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether and lumefantrine in malaria and Falciparum malaria (PF), sponsored by Ministry of Health and Population. Started Sep 2015; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12615001110572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001110572.